Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer: A Multicenter, Prospective, Multi-Cohort Study

NCT07325565 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07325565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07325565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer: A Multicenter, Prospective, Multi-Cohort Study
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 20, 2025
Completion date
December 31, 2028
Enrollment
651 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emotional disorder, liver cancer